Stada Arzneimittel AG – Strategy, SWOT and Corporate Finance Report
- Pages: 55
- Published: June 2019
- Report Code: MLPH33153FSA
Stada Arzneimittel AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company
Key Highlights
Stada Arzneimittel AG (STADA) is a manufacturer of low-cost generics and branded over the counter products. The company develops and markets drugs with off-patent active pharmaceutical ingredients, particularly, which are free from commercial property rights. It offers portfolio of products in various therapeutic categories including pain, women's health, cardiovascular conditions and diabetes. Few of its major generic products include including Tilidin Naloxon, Atorvastatin, Epoetin zeta and Diclofenac. Its major branded products include APO-Go, Grippostad, Snup, Fultium and Vitaprost. The company operates across Germany, Central Europe, CIS/Eastern Europe and Asia-Pacific. STADA is headquartered in Bad Vilbel, Germany.
Scope
Detailed information on Stada Arzneimittel AG required for business and competitor intelligence needs
A study of the major internal and external factors affecting Stada Arzneimittel AG in the form of a SWOT analysis
An in-depth view of the business model of Stada Arzneimittel AG including a breakdown and examination of key business segments
News about Stada Arzneimittel AG, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Stada Arzneimittel AG and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Stada Arzneimittel AG as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Stada Arzneimittel AGs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Vifor Pharma Ltd
Turing Pharmaceuticals AG
MorphoSys AG
MediGene AG
HC Berlin Pharma AG
Evotec AG
EGIS Pharmaceuticals Plc
Biotest AG
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.